iSpeak Blog

Read, Learn, Innovate: Top Blog Posts from October 2019

ISPE
Read, Learn, Innovate: Top Blog Posts from October 2019

Featured in this edition of iSpeak Reading Roundup, are the top blog posts from October 2019. See leading facilities, break-through therapies, innovative technologies, and more for what the pharmaceutical industry was reading in October.


Benefits of Prefabricated Modular/Podular BioPharma Facility Construction

Modular Podular

Learn more about how modular and podular construction designs can shape facilities of biopharmaceutical manufacturing. These facility designs can have the ability to address the severity of natural disasters and the impact on vulnerable populations globally.

Learn More


Meet Pfizer Inc. - 2019 Facility of the Year Project Execution Category Winner

Meet Pfizer Inc. - 2019 Facility of the Year Project Execution Category Winner

This year’s category winner proved excellence in the incorporation of novel technologies, improved efficiencies, and success in eliminating challenges. Read more about Pfizer’s first modular biological production facility!

Learn More


EU Clinical Trials Application Process

EU Clinical Trials Application Process

See the updates and new changes to EU Clinical Trial Regulation, including a single approach for the application and maintenance of the CT authorisation and this applies to trials whether they are multi-member state or mono-state.

Learn More


Common Pitfalls During Implementation of a Cleaning Validation Program

Common Pitfalls During Implementation of a Cleaning Validation Program

Review current challenges validation experts are facing when implementing programs for advanced manufacturing. Key ideas addressed are continuous validation techniques and multi-step production challenges.

Learn More


Meet AveXis - 2019 Facility of the Year Award Honorable Mention Category Winner

Meet AveXis - 2019 Facility of the Year Award Honorable Mention Category Winner

Discover how AveXis overcame challenges in execution and delivery of novel treatments for patients affected by rare and life-threatening neurological genetic diseases. The company received an Honorable Mention Award for this year’s competition.

Learn More